Fortress Biotech Corp (FBIO) Forward Price-to-Revenue Multiple

Public company logo of Fortress Biotech, Inc. (FBIO)

The forward P/S history of Fortress Biotech, Inc. (FBIO), which leverages M&A strategic expertise and subsidiary startups, demonstrates a trend where the parameter reaches 1.00. The current trajectory is based on the success of portfolio companies in bringing drugs to market, although the holding company's financial stability remains under pressure from debt obligations and regulatory risks regarding the approval of new medications.

FBIO Fortress Biotech: Market Cap to Future Revenue Ratio in the range 07/04/2022 - 11/13/2026

Summary analytical data breakdowns for Fortress Biotech Corp (FBIO)

- market price and analyst price targets:
Price Chart Fortress Biotech|FBIO - Analyst Median Target
- market capitalization details:
Market Valuation Fortress Biotech Corp|FBIO - Value Adjusted for Debt and Cash
- business book valuation details:
Net Assets per Single Share Fortress Biotech|FBIO - Total Stockholders' Equity|Market Value to Book Value Ratio fortressbiotech.com|FBIO - Total Business Assets
- debt and solvency information:
Total Debt to Capital Fortress Biotech, Inc.|FBIO - Long-Term Debt to Equity Ratio|Short-Term Debt to Equity Fortress Biotech, Inc.|FBIO - Company Cumulative Debt|Debt to Book Capitalization Ratio Fortress Biotech Corp|FBIO - Company Long-Term Debt|Company Short-Term Debt Fortress Biotech|Quick Ratio fortressbiotech.com
- business earnings and investment ratios data:
FBIO - Annual Net Income|Future Profit Fortress Biotech, Inc.|FBIO - Market Cap to Earnings|Forward P/E Multiple Fortress|FBIO - Market Cap to Earnings and Growth Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Fortress Biotech Corp|FBIO - Profit before interest, taxes and amortization|Earnings per share for the last twelve months Fortress Biotech|FBIO - Earnings per share for the trailing year|Year-over-year net earnings per share growth for the last 12 months fortressbiotech.com|FBIO - Net earnings per one share growth for the current year|Net earnings per share growth forecast for next year Fortress Biotech, Inc.
- revenue and sales details:
FBIO - Company Sales Revenue|Projected Sales Volume Fortress Biotech|FBIO - Price to Sales|Price-to-Projected Revenue Ratio Fortress Biotech Corp
Initial company analysis:FBIO (Fortress Biotech)
Product sample of Fortress Biotech, Inc.

Efficient digital capital routing into the logistics of innovative drugs at Fortress Biotech, Inc. (FBIO) directly impacts the pace of revenue scaling. The forward P/S metric reflects the market premium for this potential, determining the balance between overvaluation and undervaluation of the business through an analysis of sustainable price corridors, where deviations from the norm signal a fundamental shift in the prospects for capturing new market niches.

Who Fortress Biotech, Inc. competes with

Price-to-Projected Revenue Ratio NovoCure NVCR|Market Cap to Expected Sales Ratio Alpha Tau Medical Ltd (DRTS)|ACRV: Forward Price-to-Revenue Multiple|Forward Price to Sales ALLR (Allarity Therapeutics)